Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMandarin In.sg Regulatory News (MDO)

  • This share is currently suspended. It was suspended at a price of 1.65
  • There is currently no data for MDO

Interim Management Statement

7 May 2014 12:33

RNS Number : 4757G
Mandarin Oriental International Ltd
07 May 2014
 

To: Business Editor For immediate release

 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

7th May 2014 ‒ Mandarin Oriental International Limited has today issued its Interim Management Statement covering the period from 1st January to 6th May 2014.

 

The trading performance across the Group during the period was broadly stable. In Asia, the results of the Hong Kong and Singapore hotels remained steady, while Bangkok continued to be affected by challenging conditions. Europe benefited from further stabilization of the Paris hotel and improvement in Geneva, which more than offset softer demand in London. In The Americas, while the majority of hotels increased their average rates, the overall performance was impacted by lower demand in Washington when compared to the same period last year, which included the 2013 Presidential Inauguration.

 

In March, the Group entered into an agreement with a local development partner to expand its wholly-owned hotel in Munich. A mixed-use complex is to be constructed on an adjacent site that will include a hotel element in which the Group will have a freehold interest. The Group's total projected investment in the complex, which is due to open in 2021, is estimated at €124 million (US$170 million) in today's terms, and will include a refurbishment of the existing hotel's rooms.

 

During the period, a new management contract was announced for a 121-room luxury resort located on Bali's southern peninsula, scheduled to open in 2017. The Group has ceased management of two unbranded hotels; the Grand Lapa hotel in Macau in January and the Elbow Beach hotel in Bermuda in March.

 

Two new hotels are scheduled to open within the next six months, in Taipei, Taiwan and in Bodrum, Turkey.

 

The Group's financial position remains healthy, with net debt remaining in line with that reported at 31st December 2013.

 

On 8th April 2014 shareholders approved the transfer of the Company's share listing on the Main Market of the London Stock Exchange to the standard segment from the premium segment. The transfer is expected to become effective on 27th May 2014.

 

Mandarin Oriental Hotel Group is the award-winning owner and operator of some of the most luxurious hotels, resorts and residences. Having grown from a well-respected Asian hotel company into a global brand, the Group now operates, or has under development, 44 hotels representing close to 11,000 rooms in 25 countries, with 20 hotels in Asia, ten in The Americas and 14 in Europe, Middle East and North Africa. In addition, the Group operates or has under development, 13 Residences at Mandarin Oriental connected to its properties. Mandarin Oriental International Limited is incorporated in Bermuda and has its primary listing on the London Stock Exchange, with secondary listings in Bermuda and Singapore. It is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

 

Mandarin Oriental Hotel Group International Limited

Hamish Ross (852) 2895 9288

Sally de Souza (852) 2895 9167

 

GolinHarris

Kennes Young (852) 2501 7987

 

This and other Group announcements can be accessed through the internet at 'www.mandarinoriental.com'.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFDLFBZEFXBBL
Date   Source Headline
2nd Mar 202310:27 amRNSAudit Committee Chairman and Membership Changes
2nd Mar 20239:30 amRNSMandarin Oriental - 2022 Preliminary Results
31st Jan 202310:49 amRNSTotal Voting Rights
10th Nov 20229:42 amRNSInterim Management Statement
26th Sep 202210:21 amRNSBlock listing Interim Review
28th Jul 202210:28 amRNSHalf Year Results
18th Jul 20225:19 pmRNSMO announces Sale of MO, Washington D.C.
19th May 202210:27 amRNSInterim Management Statement
5th May 202212:40 pmRNSResult of AGM
7th Apr 202210:35 amRNSAnnual Financial Report
31st Mar 202211:34 amRNSTotal Voting Rights
25th Mar 20229:28 amRNSBlock listing Interim Review
3rd Mar 20229:29 amRNS2021 Preliminary Announcement of Results
31st Jan 20227:18 amRNSTotal Voting Rights
31st Dec 20217:01 amRNSTotal Voting Rights
30th Nov 20219:43 amRNSTotal Voting Rights
19th Nov 20219:28 amRNSDirectorate Change
11th Nov 20219:41 amRNSInterim Management Statement
22nd Oct 202110:18 amRNSDirectorate Change
27th Sep 202110:23 amRNSBlock listing Interim Review
30th Jul 202110:20 amRNSTotal Voting Rights
29th Jul 202110:38 amRNSDirectorate Change
29th Jul 202110:23 amRNS2021 HALF YEAR FINANCIAL STATEMENTS
30th Jun 202110:21 amRNSTotal Voting Rights
1st Jun 20217:02 amRNSTotal Voting Rights
20th May 20217:00 amRNSDirectorate Change
5th May 20211:25 pmRNSResult of AGM
5th May 202110:24 amRNSInterim Management Statement
30th Apr 202110:30 amRNSTotal Voting Rights
16th Apr 202110:26 amRNSHolding(s) in Company
8th Apr 202110:31 amRNSAnnual Financial Report
25th Mar 20219:27 amRNSBlock listing Interim Review
24th Mar 20219:47 amRNSDirector Declaration
11th Mar 20219:16 amRNS2020 Preliminary Announcement of Results
3rd Dec 202012:30 pmRNSDirectorate Change
5th Nov 20209:27 amRNSInterim Management Statement
27th Oct 20209:27 amRNSDirectorate Change
27th Oct 20209:21 amRNSDirectorate Change
25th Sep 202010:50 amRNSBlock listing Interim Review
25th Sep 202010:47 amRNSDirector/PDMR Shareholding
30th Jul 202011:01 amRNSHalf-year Report
15th Jun 202010:22 amRNSDirector Declaration
29th May 202010:20 amRNSTotal Voting Rights
6th May 20201:13 pmRNSNon-Routine Resolutions submitted via NSM
6th May 20201:07 pmRNSResult of AGM
9th Apr 202010:21 amRNSInterim Management Statement
9th Apr 20207:38 amRNSAdditional Listing
7th Apr 202010:30 amRNSAnnual Financial Report
30th Mar 202011:07 amRNSDirector Declaration
25th Mar 20209:27 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.